Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 456, 971-975 (18 December 2008) | doi:10.1038/nature07449; Received 23 July 2008; Accepted 16 September 2008; Published online 16 November 2008
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
nature jobs
Faculty Positions
- University of Texas Medical Branch
- Galveston, TX United States
Director
- The National Center for Complementary and Alternative Medicine (NCCAM)
- Bethesda, MD
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Maria Barna1, Aya Pusic2,5, Ornella Zollo2,5, Maria Costa2, Nadya Kondrashov1, Eduardo Rego3, Pulivarthi H. Rao4 & Davide Ruggero2
- Department of Biochemistry & Biophysics, University of California San Francisco, Rock Hall Room 384C, 1550 Fourth Street, San Francisco, California 94158-2517, USA
- School of Medicine and Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, Byers Hall Room 308E, 1700 Fourth Street, San Francisco, California 94158-2517, USA
- Center for Cell Based Therapy, Fundação Hemocentro de Ribeirão Preto, University of Sao Paulo, 14048-900 Brazil
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA
- These authors contributed equally to this work.
Correspondence to: Maria Barna1Davide Ruggero2 Correspondence and requests for materials should be addressed to M.B. (Email: maria.barna@ucsf.edu) or D.R. (Email: Davide.Ruggero@ucsf.edu).
Abstract
The Myc oncogene regulates the expression of several components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, RNA polymerase III and ribosomal DNA1, 2. Whether and how increasing the cellular protein synthesis capacity affects the multistep process leading to cancer remains to be addressed. Here we use ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in E
-Myc/+ transgenic mice to normal levels, and show that the oncogenic potential of Myc in this context is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc-overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a new mechanism that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation used to regulate the expression of selective messenger RNAs. We show that an aberrant increase in cap-dependent translation downstream of Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site (IRES)-dependent translation that is required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic-specific expression of the endogenous IRES-dependent form of Cdk11 (also known as Cdc2l and PITSLRE)3, 4, 5, which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in E
-Myc/+ mice. When accurate translational control is re-established in E
-Myc/+ mice, genome instability is suppressed. Our findings demonstrate how perturbations in translational control provide a highly specific outcome for gene expression, genome stability and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post-genomic level.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract developmentKidney International Original Article
14-3-3&sgr; controls mitotic translation to facilitate cytokinesisNature Letters to Editor (15 Mar 2007)
A role for hnRNP C1/C2 and Unr in internal initiation of translation during mitosisThe EMBO Journal Article (10 Jan 2007)
See all 18 matches for Research
